NCT01000922: A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro |
|
|
| Completed | 2 | 24 | US | Regular Human Insulin, Lispro, VIAject, VIAject 50%, VIAject/Insulin Glargine, Insulin Glargine/VIAject | Biodel | Diabetes Mellitus | 01/08 | 01/08 | | |
